Heartvet Solutions Limited 14722555 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true 14722555 2025-04-01 2026-03-31 14722555 2026-03-31 14722555 core:RetainedEarningsAccumulatedLosses 2026-03-31 14722555 core:ShareCapital 2026-03-31 14722555 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 14722555 bus:SmallEntities 2025-04-01 2026-03-31 14722555 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 14722555 bus:FullAccounts 2025-04-01 2026-03-31 14722555 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 14722555 bus:RegisteredOffice 2025-04-01 2026-03-31 14722555 bus:Director1 2025-04-01 2026-03-31 14722555 bus:Director2 2025-04-01 2026-03-31 14722555 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14722555 core:OfficeEquipment 2025-04-01 2026-03-31 14722555 core:PlantMachinery 2025-04-01 2026-03-31 14722555 countries:AllCountries 2025-04-01 2026-03-31 14722555 2025-03-31 14722555 2024-04-01 2025-03-31 14722555 2025-03-31 14722555 core:RetainedEarningsAccumulatedLosses 2025-03-31 14722555 core:ShareCapital 2025-03-31 14722555 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 14722555

Heartvet Solutions Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2026

 

Heartvet Solutions Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Heartvet Solutions Limited

(Registration number: 14722555)
Abridged Balance Sheet as at 31 March 2026

Note

2026
£

2025
£

Fixed assets

 

Tangible assets

4

16,866

29,199

Current assets

 

Stocks

5

18,723

20,383

Debtors

44,365

53,024

Cash at bank and in hand

 

98,217

62,775

 

161,305

136,182

Creditors: Amounts falling due within one year

(75,234)

(55,798)

Net current assets

 

86,071

80,384

Total assets less current liabilities

 

102,937

109,583

Provisions for liabilities

(775)

(3,102)

Net assets

 

102,162

106,481

Capital and reserves

 

Called up share capital

400

400

Profit and loss account

101,762

106,081

Total equity

 

102,162

106,481

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 25 September 2026 and signed on its behalf by:
 

Mrs J Harris

Director

Mr D Dickson

Director

 

Heartvet Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Waldenfields
Whitestone
Exeter
Devon
EX4 2HP

These financial statements were authorised for issue by the Board on 25 September 2026.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant & machinery

25% Straight line

Office equipment

25% Straight line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

 

Heartvet Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 7 (2025 - 6).

4

Tangible assets

Total
£

Cost or valuation

At 1 April 2025

49,332

At 31 March 2026

49,332

Depreciation

At 1 April 2025

20,133

Charge for the year

12,333

At 31 March 2026

32,466

Carrying amount

At 31 March 2026

16,866

At 31 March 2025

29,199

5

Stocks

2026
£

2025
£

Stock

18,723

20,383